Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $73,257 | 41 | 50.6% |
| Consulting Fee | $48,741 | 35 | 33.7% |
| Food and Beverage | $13,799 | 848 | 9.5% |
| Travel and Lodging | $6,728 | 27 | 4.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,650 | 1 | 1.1% |
| Education | $499.50 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HARMONY BIOSCIENCES LLC | $69,341 | 84 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $52,429 | 268 | $0 (2024) |
| Axsome Therapeutics, Inc. | $13,839 | 30 | $0 (2024) |
| ABBVIE INC. | $2,296 | 123 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,393 | 94 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,157 | 81 | $0 (2022) |
| Allergan, Inc. | $793.68 | 90 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $633.62 | 39 | $0 (2024) |
| Corium, LLC | $513.53 | 33 | $0 (2024) |
| Alkermes, Inc. | $395.59 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,024 | 85 | Axsome Therapeutics, Inc. ($6,941) |
| 2023 | $36,039 | 140 | Harmony Biosciences LLC ($20,710) |
| 2022 | $25,051 | 130 | Harmony Biosciences LLC ($16,305) |
| 2021 | $19,169 | 140 | HARMONY BIOSCIENCES LLC ($17,326) |
| 2020 | $15,562 | 128 | Harmony Biosciences LLC ($9,629) |
| 2019 | $3,817 | 91 | JAZZ PHARMACEUTICALS INC. ($3,190) |
| 2018 | $12,315 | 122 | Jazz Pharmaceuticals Inc. ($11,503) |
| 2017 | $18,695 | 126 | Jazz Pharmaceuticals Inc. ($17,994) |
All Payment Transactions
962 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $15.20 | General |
| 12/12/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Consulting Fee | Cash or cash equivalent | $654.00 | General |
| Category: Narcoplepsy | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: CNS | ||||||
| 12/05/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: CNS | ||||||
| 11/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $80.20 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 11/12/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: CNS | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/22/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $2.32 | General |
| 10/21/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $24.70 | General |
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: CNS | ||||||
| 10/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Consulting Fee | Cash or cash equivalent | $654.00 | General |
| Category: Narcoplepsy | ||||||
| 10/15/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: CNS | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $13.98 | General |
| 09/12/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $1.69 | General |
| 09/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: CNS | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $90.76 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 221 | 505 | $102,940 | $40,840 |
| 2022 | 6 | 321 | 845 | $184,490 | $78,984 |
| 2021 | 7 | 398 | 1,084 | $234,141 | $101,820 |
| 2020 | 8 | 384 | 958 | $229,630 | $68,883 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 34 | 141 | $35,250 | $14,210 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 178 | $35,600 | $13,809 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 40 | $10,600 | $4,109 | 38.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 27 | 60 | $10,500 | $4,041 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 50 | $7,750 | $2,776 | 35.8% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 16 | 36 | $3,240 | $1,895 | 58.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 207 | $54,855 | $26,248 | 47.8% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 49 | 218 | $54,500 | $22,560 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 262 | $52,400 | $20,151 | 38.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 27 | 65 | $11,375 | $4,606 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 46 | $7,130 | $2,915 | 40.9% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 23 | 47 | $4,230 | $2,506 | 59.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 399 | $79,786 | $33,542 | 42.0% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 43 | 261 | $65,223 | $27,275 | 41.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 80 | 203 | $53,668 | $26,386 | 49.2% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 32 | 100 | $17,309 | $6,927 | 40.0% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 21 | 53 | $4,888 | $2,984 | 61.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 57 | $8,835 | $2,827 | 32.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,431 | $1,879 | 42.4% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 54 | 271 | $67,750 | $24,114 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 150 | 369 | $73,800 | $23,244 | 31.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 38 | 84 | $14,700 | $5,499 | 37.4% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2020 | 12 | 12 | $39,600 | $5,029 | 12.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 100 | $15,500 | $4,135 | 26.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 25 | 38 | $10,070 | $3,195 | 31.7% |
About Dr. Debra Stultz, M.D
Dr. Debra Stultz, M.D is a Psychiatry healthcare provider based in Barboursville, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346249836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Stultz, M.D has received a total of $144,674 in payments from pharmaceutical and medical device companies, with $14,024 received in 2024. These payments were reported across 962 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($73,257).
As a Medicare-enrolled provider, Stultz has provided services to 1,324 Medicare beneficiaries, totaling 3,392 services with total Medicare billing of $290,527. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Sleep Medicine
- Location Barboursville, WV
- Active Since 07/18/2005
- Last Updated 10/23/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346249836
Products in Payments
- Wakix (Drug) $40,459
- Xyrem (Drug) $29,497
- WAKIX (Drug) $26,081
- Sunosi (Drug) $13,662
- XYWAV (Drug) $11,343
- XYREM (Drug) $6,059
- SUNOSI (Drug) $5,038
- VRAYLAR (Drug) $2,689
- LATUDA (Drug) $1,157
- AUSTEDO (Drug) $835.94
- REXULTI (Drug) $707.94
- Azstarys (Drug) $300.93
- SPRAVATO (Drug) $256.57
- Austedo XR (Drug) $244.38
- AZSTARYS (Drug) $212.60
- UBRELVY (Drug) $185.25
- Auvelity (Drug) $177.56
- LYBALVI (Drug) $176.70
- ARISTADA (Drug) $171.35
- TRINTELLIX (Drug) $170.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.